Orphazyme A/S Company Top Insiders

OZYMF Stock  USD 90.00  0.00  0.00%   
Orphazyme A/S employs about 2 people. The company is managed by 2 executives with a total tenure of roughly 5 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Examination of Orphazyme A/S's management performance can provide insight into the company performance.
MBA MSc  Insider
CFO CEO
Jennifer McCann  Insider
I US
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Orphazyme AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.

Orphazyme A/S Management Team Effectiveness

The company has return on total asset (ROA) of (1.334) % which means that it has lost $1.334 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (4.8658) %, meaning that it generated substantial loss on money invested by shareholders. Orphazyme A/S's management efficiency ratios could be used to measure how well Orphazyme A/S manages its routine affairs as well as how well it operates its assets and liabilities.

Orphazyme A/S Workforce Comparison

Orphazyme AS is rated below average in number of employees category among its peers. The total workforce of Biotechnology industry is now estimated at about 168. Orphazyme A/S claims roughly 2.0 in number of employees contributing just under 2% to stocks in Biotechnology industry.
The company has Profit Margin (PM) of (2.76) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (15.38) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $15.38.

Orphazyme A/S Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Orphazyme A/S Price Series Summation is a cross summation of Orphazyme A/S price series and its benchmark/peer.

Orphazyme A/S Notable Stakeholders

An Orphazyme A/S stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Orphazyme A/S often face trade-offs trying to please all of them. Orphazyme A/S's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Orphazyme A/S's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.

About Orphazyme A/S Management Performance

The success or failure of an entity such as Orphazyme A/S often depends on how effective the management is. Orphazyme A/S management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Orphazyme management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Orphazyme management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Orphazyme AS, a biopharmaceutical company, develops therapies for the treatment of neurodegenerative rare diseases. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark. Orphazyme is traded on OTC Exchange in the United States.

Orphazyme A/S Workforce Analysis

Traditionally, organizations such as Orphazyme A/S use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Orphazyme A/S within its industry.

Orphazyme A/S Manpower Efficiency

Return on Orphazyme A/S Manpower

Revenue Per Employee18.1M
Revenue Per Executive18.1M
Net Loss Per Employee313.3M
Net Loss Per Executive313.3M

Complementary Tools for Orphazyme Pink Sheet analysis

When running Orphazyme A/S's price analysis, check to measure Orphazyme A/S's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orphazyme A/S is operating at the current time. Most of Orphazyme A/S's value examination focuses on studying past and present price action to predict the probability of Orphazyme A/S's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orphazyme A/S's price. Additionally, you may evaluate how the addition of Orphazyme A/S to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like